Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 7, 2024 -- There is a negative association between travel time to tanning facilities and county-level melanoma incidence rates, according to a study published online Nov. 7 in the Journal of Investigative Dermatology.
Guixing Wei, Ph.D., from Brown University in Providence, Rhode Island, and colleagues examined the association between melanoma incidence and access to tanning bed facilities using data for New England county-level melanoma incidence rates for 2014 to 2018, tanning bed facilities location, demographic data, socioeconomic data, and geographic data.
The researchers found that for every one-minute increase in average travel time to tanning facilities within a 30-minute travel time threshold, there was a decrease in melanoma incidence by 3.46 and 1.92 percent in the same county and across New England, respectively. A negative association was identified between average travel time to tanning facilities and county-level melanoma incidence rate. With respect to county-level melanoma rate, six high-risk clusters and seven low-risk clusters were identified.
"The identification of clusters of melanoma incidence can help inform the strategic targeting of interventions and resources that aim to reduce the burden of melanoma," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-09 00:00
Read more
- First U.S. Case of New Mpox Strain Spotted in Traveler
- Nursing-Sensitive Quality Indicators Negatively Impacted by Pandemic
- 'Dawson's Creek' Star James Van Der Beek Has Colon Cancer
- Dose-Dependent Association Seen for Smoking, CVD Risk
- Rates of Anxiety, Depression Rising Among Americans, Especially the Young
- Even Hardcore Smokers May Quit If Given Right Tools, Study Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions